Distal embolic protection in patients with acute myocardial infarction: Attractive concept but no evidence of benefit

JAMA

Volumn 293, Issue 9, 2005, Pages 1116-1118

  Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ANGIOGRAPHY; ARTIFICIAL EMBOLISM; BALLOON OCCLUSION; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; EDITORIAL; HEART INFARCTION PREVENTION; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; HEART INFARCTION; MICROCIRCULATION; NOTE; SUCTION; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; SUCTION; THROMBOEMBOLISM;

EID: 14144250914     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.9.1116     Document Type: Editorial

References (26)

1. Roe MT, Ohman EM, Maas AC, et al. Shifting the open-artery hypothesis down-stream: the quest for optimal reperfusion. J Am Coll Cardiol. 2001;37:9-18.
2. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656-662.
3. Gibson CM, Schömig A. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation. 2004;109:3096-3105.
4. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the "no reflow" phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-228.
5. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 2000;101:570-580.
6. de Feyter PJ. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem. Circulation. 2003;107:2284-2286.
7. Bejarano J. Mechanical protection of cardiac microcirculation during percutaneous coronary interevntion of saphenous vein grafts. Int J Cardiol. In press.
8. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation. 2002;105:1285-1290.
9. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548-553.
10. Boston Scientific 2003 Annual Report. Available at: http://www. bostonscientific .com/templatedata/imports/collateral/AboutBSC/ oth_2003annualreport_us .pdf. Accessed January 29, 2005.
11. Medtronic 2004 Annual Report. Available at: http://www.medtronic.com /annual_reports/annual04/dcvascular.html. Accessed January 29, 2005.
12. Limbruno U, Micheli A, De Carlo M, et al. Mechanical prevention of distal embolization during primary angioplasty: safety, feasibility, and impact on myocardial reperfusion. Circulation. 2003;108:171-176.
13. Huang Z, Katoh O, Nakamura S, Negoro S, Kobayashi T, Tanigawa J. Evaluation of the PercuSurge Guardwire Plus temporary occlusion and aspiration system during primary angioplasty in acute myocardial infarction. Catheter Cardiovasc Interv. 2003;60:443-451.
14. Yip HK, Wu CJ, Chang HW, et al. Effect of the PercuSurge GuardWire device on the integrity of microvasculature and clinical outcomes during primary transradial coronary intervention in acute myocardial infarction. Am J Cardiol. 2003;92:1331-1335.
15. Orrego PS, Delgado A, Piccalo G, Salvade P, Bonacina E, Klugmann S. Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction: single-center experience. Catheter Cardiovasc Interv. 2003;60:152-158.
16. Nakamura T, Kubo N, Seki Y, et al. Effects of a distal protection device during primary stenting in patients with acute anterior myocardial infarction. Circ J. 2004;68:763-768.
17. Taguchi I, Kanaya T, Toi T, et al. Comparison of the effects of a distal embolic protection device and an aspiration catheter during percutaneous coronary intervention in patients with acute myocardial infarction. Circ J. 2005;69:49-54.
18. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293:1063-1072.
19. Rogers C, Huynh R, Seifert PA, et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation. 2004;109:1735-1740.
20. Gick M, Jander N, Bestehorn HP, et al. Randomized study on the effectiveness of a filter device for distal protection during direct percutaneous catheter intervention for acute myocardial infarction: results of the PROMISE (Protection Devices in PCI-Treatrnent of Myocardial Infarction for Salvage of Endangered Myocardium) Study. Presented at: Late Breaking Clinical Trials: 54th Annual Scientific Session of the American College of Cardiology; March 6-9, 2005; Orlando, Fla.
21. Schömig A, Ndrepepa G, Mehilli J, et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol. 2004;44:2073-2079.
22. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998;98:2695-2701.
23. Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol. 2002;40:1199-1204.
24. Mahaffey KW, Granger CB, Nicolau JC, et al. Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the Complement Inhibition in Myocardial Infarction Treated With Thrombolytics (COMPLY) trial. Circulation. 2003;108:1176-1183.
25. theHeart.org. COOL-MI: no reduction in infarct size in acute MI patients undergoing cooling therapy before PCI. Available at: http://www.theheart.org/ viewArticle .do?primaryKey=240285. Accessed January 29, 2005.
26. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.